Longitudinal patterns of antidepressant prescribing in primary care in the UK: Comparison with treatment guidelines

Journal of Psychopharmacology

Volumn 13, Issue 2, 1999, Pages 136-143

  Dunn, Rodney L ^a   Donoghue, John M ^b   Ozminkowski, Ronald J ^c   Stephenson, Deborah ^d   Hylan, Timothy R ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PCS Health   (United Kingdom)

^c MEDSTAT Group   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Antidepressants; Depression; Drug prescribing patterns; Selective serotonin reuptake inhibitors; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOSULEPIN; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; DATA BASE; DEPRESSION; DRUG CHOICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0033027095     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300204     Document Type: Article

References (32)

1. Agency for Health Care Policy Research (1993) Treatment of major depression: clinical practice guidelines. AHCPR Publication 93-0550;1(5)
2. Anderson I M, Tomenson B M (1994) The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8: 238-249
3. Ashcraft M L F, Fries B E, Nerenz D R, Falcon S P, Srivastava S V, Lee C Z (1989) A psychiatric patient classification system: an alternative to diagnosis-related groups. Med Care 27: 543-557
4. Benkert O, Szegedi A, Wetzel H (1996) Minimum effective dose for antidepressants - an obligatory requirement for antidepressant drug evaluation? Int Clin Psychopharmacol 11: 177-185
5. British Association for Psychopharmacology (1993) Guidelines for treating depressive illness with antidepressants. J Psychopharmacol 7:19-23
6. Canadian Coordinating Office of Health Care Technology Assessment (1998) A clinical and economic evaluation of selective serotonin reuptake inhibitors in major depression. Ontario, Canada
7. Donoghue J M (1995) A comparison of prescribing patterns of selective serotonin reuptake inhibitors in the treatment of depression in primary care in the United Kingdom. J Serotonin Res 1: 47-51
8. Donoghue J M (1996) Prescribing patterns of selective serotonin reuptake inhibitors in primary care: a naturalistic follow-up study. J Serotonin Res 4: 267-270
9. Donoghue J M, Tylee A (1996) The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168: 164-168
10. Donoghue J M, Tylee A, Wildgust H (1996) Cross-sectional database analysis of antidepressant prescribing in general practice in the United Kingdom. BMJ 313: 811-812
11. Effective Health Care Bulletin (1993) The treatment of depression in primary care. Effective Health Care Bull 5: 1-12
12. Fairman K (1997) The doctor told me to cut the pills in half: practical considerations in using claims databases for outcomes research. Drug Benefit Trends 9: 30-36
13. Farmer R (1997) Managing depression: a matter of record. Primary Care Psychiatry 3 (Suppl. 1): S11-S16
14. Henry J A (1995) Relative mortality from overdose of antidepressants. BMJ 310: 221-224
15. Hotopf M, Lewis G, Normand C (1996) Are SSRIs a cost-effective alternative to tricyclics? Br J Psychiatry 168: 404-409
16. Katon W, Von Korff M, Lin E, Bush T, Ormel J (1992) Adequacy and duration of antidepressant treatment in primary care. Med Care 30: 67-76
17. MacDonald T M (1997) Treatment of depression: prescription for success? Primary Care Psychiatry 3 (Suppl. 1): S7-S10
18. Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L (1992) Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 149: 795-800
19. Martin R M, Hilton S R, Kerry S M, Richards N M (1997) General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. BMJ 314: 646-651
20. Matthews K, Eagles J M, Matthews C A (1993) The use of antidepressant drugs in general practice. Eur J Clin Pharmacol 45: 205-210
21. Mintz J, Mintz L I, Arruda M J, Hwang S S (1992) Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 49: 761-768
22. Moore M V (1997) More on what is an effective dose [letter]. BMJ 314: 827
23. Montgomery S A (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9: 47-53
24. Priest R G (1994) Improving the management and knowledge of depression. Br J Psychiatry 164: 285-287
25. Royal College of Psychiatrists (1992) Recognition and management of depression in general practice. BMJ 205: 1198-1202
26. Simon G E, Fishman P (1998) Cost implications of initial antidepressant selection in primary care. Pharmacoeconomics 13: 61-70
27. Simon G E, Von Korff M, Wagner E H, Barlow W (1993) Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 15: 399-408
28. Simon G E, Von Korff M, Heiligenstein J H, Revicki D A, Grothaus L, Katon W et al. (1996) Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs. tricyclic antidepressants. JAMA 275: 1897-1902
29. Song F, Freemantle N, Sheldon TA (1994) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 306: 683-687
30. Sturm R, Wells K (1995) How can care for depression become more cost-effective? JAMA 273: 51-58
31. Tan R S (1997) Low dose tricyclic antidepressants are effective in treating major depression [letter]. BMJ 314: 827
32. World Health Organization Mental Health Collaborating Centers (1989) Pharmacotherapy of depressive disorders: WHO consensus statement. J Affect Disord 17: 197-198